Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
Morgenstern DA, Pötschger U, Moreno L, Papadakis V, Owens C, Ash S, Pasqualini C, Luksch R, Garaventa A, Canete A, Elliot M, Wieczorek A, Laureys G, Kogner P, Malis J, Ruud E, Beck-Popovic M, Schleiermacher G, Valteau-Couanet D, Ladenstein R. Morgenstern DA, et al. Among authors: luksch r. Pediatr Blood Cancer. 2018 Nov;65(11):e27363. doi: 10.1002/pbc.27363. Epub 2018 Jul 17. Pediatr Blood Cancer. 2018. PMID: 30015396
Neuroblastoma in adolescents: the Italian experience.
Conte M, Parodi S, De Bernardi B, Milanaccio C, Mazzocco K, Angelini P, Viscardi E, Di Cataldo A, Luksch R, Haupt R. Conte M, et al. Among authors: luksch r. Cancer. 2006 Mar 15;106(6):1409-17. doi: 10.1002/cncr.21751. Cancer. 2006. PMID: 16475209 Free article.
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide.
Formelli F, Cavadini E, Luksch R, Garaventa A, Villani MG, Appierto V, Persiani S. Formelli F, et al. Among authors: luksch r. Cancer Chemother Pharmacol. 2008 Sep;62(4):655-65. doi: 10.1007/s00280-007-0649-7. Epub 2007 Dec 8. Cancer Chemother Pharmacol. 2008. PMID: 18066548 Clinical Trial.
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S. Spreafico F, et al. Among authors: luksch r. Pediatr Blood Cancer. 2008 Jul;51(1):23-8. doi: 10.1002/pbc.21524. Pediatr Blood Cancer. 2008. PMID: 18293386 Clinical Trial.
Retrospective study of childhood ganglioneuroma.
De Bernardi B, Gambini C, Haupt R, Granata C, Rizzo A, Conte M, Tonini GP, Bianchi M, Giuliano M, Luksch R, Prete A, Viscardi E, Garaventa A, Sementa AR, Bruzzi P, Angelini P. De Bernardi B, et al. Among authors: luksch r. J Clin Oncol. 2008 Apr 1;26(10):1710-6. doi: 10.1200/JCO.2006.08.8799. J Clin Oncol. 2008. PMID: 18375900
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry.
Garaventa A, Parodi S, De Bernardi B, Dau D, Manzitti C, Conte M, Casale F, Viscardi E, Bianchi M, D'Angelo P, Zanazzo GA, Luksch R, Favre C, Tamburini A, Haupt R. Garaventa A, et al. Among authors: luksch r. Eur J Cancer. 2009 Nov;45(16):2835-42. doi: 10.1016/j.ejca.2009.06.010. Epub 2009 Jul 16. Eur J Cancer. 2009. PMID: 19616426
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
Passoni L, Longo L, Collini P, Coluccia AM, Bozzi F, Podda M, Gregorio A, Gambini C, Garaventa A, Pistoia V, Del Grosso F, Tonini GP, Cheng M, Gambacorti-Passerini C, Anichini A, Fossati-Bellani F, Di Nicola M, Luksch R. Passoni L, et al. Among authors: luksch r. Cancer Res. 2009 Sep 15;69(18):7338-46. doi: 10.1158/0008-5472.CAN-08-4419. Epub 2009 Sep 1. Cancer Res. 2009. PMID: 19723661
196 results